Apo-Methylphenidate ER 27 mg (Methylphenidate Hydrochloride TABLET (EXTENDED-RELEASE)) 27 MG

APO-METHYLPHENIDATE ER 27 MG is an extended-release tablet containing methylphenidate hydrochloride. It is commonly used for attention deficit hyperactivity disorder (ADHD) management. This medication helps improve focus and reduce impulsivity.

Strength

27 MG

Pack Size

100

Manufacturer / TM Owner

APOTEX INC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

APO-METHYLPHENIDATE ER 27 MG is primarily used for the treatment of attention deficit hyperactivity disorder (ADHD). It works by affecting certain chemicals in the brain that may be unbalanced in individuals with ADHD. This helps improve focus, concentration, and reduce impulsivity. The extended-release formulation ensures a steady release of the medication over time, providing long-lasting effects.

Side Effects

Common effects of APO-METHYLPHENIDATE ER 27 MG may include increased alertness, improved focus, and reduced impulsivity. Some individuals may experience side effects such as decreased appetite, trouble sleeping, or mild stomach upset. These effects can vary from person to person.

Precautions & Warnings

APO-METHYLPHENIDATE ER 27 MG should be handled with care. It is important to follow the prescribed dosage and administration instructions provided by a healthcare professional. This medication should be stored in a safe place, out of reach of children and pets. Always consult a healthcare provider before starting or stopping any medication.

Avoid Interactions

APO-METHYLPHENIDATE ER 27 MG may interact with certain medications, including other stimulants, antidepressants, and some over-the-counter drugs. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol and other substances that affect the central nervous system should be avoided while taking this medication.

Frequently Asked Questions

APO-METHYLPHENIDATE ER 27 MG is used for the management of attention deficit hyperactivity disorder (ADHD).

It affects certain chemicals in the brain that may be unbalanced in individuals with ADHD, helping to improve focus and reduce impulsivity.

Common side effects may include decreased appetite, trouble sleeping, and mild stomach upset.

It may interact with certain medications, so it is important to consult a healthcare provider before combining it with other drugs.

The safety and effectiveness of APO-METHYLPHENIDATE ER 27 MG in children should be discussed with a healthcare provider.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.